Advancing cell therapy: Optimizing the cell culture environment for high-quality manufacture of suspension and adherent cells

Cell and gene therapy requires manufacturing platforms that support the growth of both suspension and adherent cell types while meeting stringent quality and scalability standards.

In this webinar, two experts will explore advanced manufacturing strategies and GMP-compliant solutions for expanding mesenchymal stromal cells (MSCs), induced pluripotent stem cells (iPSCs), T cells, and CAR-T cells.

The webinar will address key topics, including:

• Methods for expanding CAR-T cells from very low quantities of starting material to therapeutic doses
• Tailoring expansion parameters to enhance Tscm frequency for better outcomes
• Leveraging automated sensing technologies to maintain optimal growth conditions for consistent, high-quality results.

Join us to discover how innovative manufacturing approaches can drive efficiency, scalability, and the production of high-quality cell therapy products.

In this webinar you will learn more about:

• Delivering a consistent and customized cell expansion environment utilizing hollow-fiber perfusion technology
• Enhancing GMP compliance and process standardization
• Scaling up and out to manufacture high-quality suspension and adherent cells efficiently

Mindy Miller

Head of Cell Therapy Scientific Development at Terumo Blood and Cell Technologies

Mindy Miller currently serves as the Sr. Manager of Cell Therapy Scientific Affairs at Terumo BCT. She holds a doctorate in Immunology from the University of Missouri and conducted post-doctoral studies at the University of Missouri and National Jewish Health in Denver, CO. Mindy’s expertise has focused on the development of immune cells in the context of autoimmunity, allergy, and cancer. She has authored over 30 scientific publications, obtained independent funding, and is the recipient of the Young Investigator Award from the American Association of Immunologists.

Nathan Frank

Senior Research Scientist at Terumo Blood and Cell Technologies

Nate has more than a decade of experience optimizing parameters for cell and gene therapy production and scale-up. He has specialized expertise in hollow-fiber bioreactor process development for a range of cell types aimed at various applications in regenerative medicine and immunotherapy. He is a two-time National Science Foundation fellow and has a passion for teaching and communicating science to a wide range of audiences from established professionals to middle and high school students who are just beginning their scientific journey.

Watch now

SPEAKERS

Mindy Miller

Head of Cell Therapy Scientific Development at Terumo Blood and Cell Technologies

Nathan Frank

Senior Research Scientist at Terumo Blood and Cell Technologies

You might also like

Accelerate the scale-up to clinical phase: optimizing stem cell culture performance and viral vector titers

Sara Bursomanno

24 April 2024

Watch

Optimizing access to high quality, standardized, and compliant leukopaks for the development and commercialization of allogeneic therapies

Makensie Becker

18 April 2024

Watch

Closed and automated CAR-T production: a fast, simple workflow for high-dose, high-quality cells

Wenyan Leong, Louise Tan

19 February

Watch

Advancing viral vector manufacturing with innovation: the importance of the cell line

Marguerite Campbell, Brian Tomkowicz

5 September 2024

Watch